日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Provisioning the Ritual Neolithic Site of Kfar HaHoresh, Israel at the Dawn of Animal Management

在动物管理初期,为以色列卡法尔哈霍雷什新石器时代仪式遗址提供物资

Meier, Jacqueline S; Goring-Morris, A Nigel; Munro, Natalie D

Insights into the Social Structure of the PPNB Site of Kfar HaHoresh, Israel, Based on Dental Remains

基于牙齿遗骸对以色列卡法尔哈霍雷什前陶新石器时代晚期遗址社会结构的深入研究

Alt, Kurt W; Benz, Marion; Vach, Werner; Simmons, Tal L; Goring-Morris, A Nigel

AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo

AZD3514:一种小分子,可在体外和体内调节雄激素受体信号传导和功能。

Sarah A Loddick,Sarah J Ross, Andrew G Thomason, David M Robinson, Graeme E Walker, Tom P J Dunkley, Sandra R Brave, Nicola Broadbent, Natalie C Stratton, Dawn Trueman, Elizabeth Mouchet, Fadhel S Shaheen, Vivien N Jacobs, Marie Cumberbatch, Joanne Wilson, Rhys D O Jones, Robert H Bradbury, Alfred Rabow, Luke Gaughan, Chris Womack, Simon T Barry, Craig N Robson, Susan E Critchlow, Stephen R Wedge, A Nigel Brooks

AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family

AZD4547:一种口服生物可利用、有效且选择性的成纤维细胞生长因子受体酪氨酸激酶家族抑制剂

Paul R Gavine, Lorraine Mooney, Elaine Kilgour, Andrew P Thomas, Katherine Al-Kadhimi, Sarah Beck, Claire Rooney, Tanya Coleman, Dawn Baker, Martine J Mellor, A Nigel Brooks, Teresa Klinowska

Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models

通过使用患者来源的肿瘤异种移植模型,将 AZD4547 的治疗潜力转化为 FGFR1 扩增的非小细胞肺癌

Jingchuan Zhang, Lin Zhang, Xinying Su, Ming Li, Liang Xie, Florian Malchers, ShuQiong Fan, XiaoLu Yin, YanPing Xu, Kunji Liu, Zhengwei Dong, Guanshan Zhu, Ziliang Qian, Lili Tang, Jakob Schöttle, Ping Zhan, Qunsheng Ji, Elaine Kilgour, Paul D Smith, A Nigel Brooks, Roman K Thomas, Paul R Gavine